Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

B cells behaving badly.

Youn K Shim1, Sharon R Silver, Neil E Caporaso

  • 1Division of Health Studies, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA. YShim@cdc.gov

British Journal of Haematology
|November 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

100 years of Personal Badge Radiation Doses in a Cohort of U.S. Radiologic Technologists: Expanded and Updated Reconstruction, 1916-2020.

Radiation research·2026
Same author

Solar ultraviolet radiation exposure, and incidence of childhood (0-19 years) malignant and non-malignant brain tumour in a US population-based dataset, 2000-2021.

European journal of epidemiology·2025
Same author

Low-dose occupational ionising radiation exposure and gastrointestinal cancer mortality among US radiologic technologists, 1983-2021.

Occupational and environmental medicine·2025
Same author

Determinants of geographic variation in the incidence of adult nonmalignant meningioma in the United States, 2010-2019.

Cancer·2025
Same author

Temporal patterns in US population-based patient survival among adults treated with chemotherapy and/or immunotherapy for multiple myeloma, 2000-2020.

British journal of haematology·2025
Same author

Residential ambient ultraviolet B and ultraviolet A and incidence of keratinocyte carcinoma in the nationwide US Radiologic Technologists cohort.

The British journal of dermatology·2025
Same journal

Author response to Zhang and Chen.

British journal of haematology·2026
Same journal

Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

British journal of haematology·2026
Same journal

Prospective, multicentre phase II study to evaluate the clinical benefit of reduced-dose lenalidomide and dexamethasone based on frailty stratification in elderly, unfit patients with newly diagnosed multiple myeloma.

British journal of haematology·2026
Same journal

Real-world effectiveness and safety of acalabrutinib in chronic lymphocytic leukaemia: Multicentre experience.

British journal of haematology·2026
Same journal

Novel germline GATA1s-generating variant associates with somatic STAG2 variants in hypoplastic myelodysplastic neoplasm.

British journal of haematology·2026
Same journal

The Endothelial Activation and Stress Index (EASIX) at diagnosis is associated with survival in primary central nervous system lymphoma.

British journal of haematology·2026
See all related articles

Monoclonal B-cell lymphocytosis may serve as a biomarker for understanding B-cell lymphoproliferative disorders. Research into environmental and genetic factors aims to improve treatments and immune system understanding.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • B-cell lymphoproliferative disorders, including chronic lymphocytic leukemia, stem from immune dysfunction and genetic changes in B cells.
  • These aberrations may originate independently or be triggered by environmental factors like infections, antigens, toxins, or radiation.

Framework:

  • Monoclonal B-cell lymphocytosis (MBL) is proposed as a key intermediate biomarker.
  • MBL can help elucidate the interplay between environmental exposures and genetic factors in disease development.

Implementation:

  • This content introduces papers from a 2007 International Workshop on MBL and Chronic Lymphocytic Leukemia (CLL).
  • The workshop focused on environmental and genetic risk factors contributing to these conditions.

Related Experiment Videos

Implications:

  • Further research is expected to yield enhanced interventions and more accurate biomarkers for CLL.
  • Understanding these factors will lead to more effective treatments and a deeper appreciation of lifelong immune system function.